5-Methyl-3,4-diphenylisoxazole
5-Methyl-3,4-diphenylisoxazole Basic information
- Product Name:
- 5-Methyl-3,4-diphenylisoxazole
- Synonyms:
-
- Valdecoxib Impurity 10 (Desulfonamide)
- 4-diphenyl-(Parecoxib sodiuM inteMediate)
- 5-Methyl-3
- Parecoxib impurity 5/5-methyl-3,4-diphenylisoxazole
- Isoxazole, 5-Methyl-3,4-diphenyl- (Parecoxib sodiuM inteMediate)
- Isoxazole, 5-Methyl-3,4-diphenyl-
- 3,4-Diphenyl-5-methylisoxazole
- 5-Methyl-3,4-diphenylisoxazole
- CAS:
- 37928-17-9
- MF:
- C16H13NO
- MW:
- 235.28
- EINECS:
- 1592732-453-0
- Product Categories:
-
- API
- Mol File:
- 37928-17-9.mol
5-Methyl-3,4-diphenylisoxazole Chemical Properties
- Melting point:
- 96.0 to 100.0 °C
- Boiling point:
- 340.1±21.0 °C(Predicted)
- Density
- 1.108±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
- form
- Solid
- pka
- -2.53±0.50(Predicted)
- color
- White to Off-White
- InChIKey
- ZXIRUKJWLADSJS-UHFFFAOYSA-N
5-Methyl-3,4-diphenylisoxazole Usage And Synthesis
Uses
5-Methyl-3,4-diphenylisoxazole is synthesis The key intermediate of Parecoxib Sodium (Parecoxib Sodium).Parecoxib Sodium is by the Pfizer of the U.S. The cox 2 inhibitor of company's research and development, listed in European Union in 2002, trade name Dynastat, is used for The short term therapy of postoperative pain.
Uses
5-Methyl-3,4-diphenylisoxazole is a reagent for the preparation of valdecoxib and valdecoxib analogues.
Synthesis
In four mouthfuls of round-bottomed flasks of a 1L add compound 2 (40g), methanol (400mL), 7.7% Aqueous sodium carbonate (400mL), is heated to 70 DEG C, after stirring reaction 2h, and TLC plate monitoring raw material Fundamental reaction is complete, and solution is divided into solid-liquid biphase, is extracted with ethyl acetate, collected organic layer, with anhydrous Sodium sulfate is dried, and vacuum obtains white solid, HPLC purity: 94.9% after being spin-dried for.White solid uses 40ml ethyl acetate and the mixed solvent recrystallization of 120ml normal hexane (1:3) again, Obtaining target compound is white solid 34.2g, yield 92%, HPLC purity: 99.7%.m.p.97-98??£? MS(m/z):236(M+H)+£?1H NMR(400MHz,CDCl3) |?:2.43(s,3H,-CH3), 7.19-7.43 (m, 10H ,-CH=).
5-Methyl-3,4-diphenylisoxazoleSupplier
- Tel
- 021-021-36680027 15800370750
- 1706640024@qq.com
- Tel
- 13327700685
- sales@vcarepharmatech.com
- Tel
- 028-87608726 13540107218
- sales@cdclimb.com
- Tel
- 0531-88581623 18805314509
- 1456922171@126.com
- Tel
- 022-60182192,1339732154 18722583064
- marketing@pharmacn.com
5-Methyl-3,4-diphenylisoxazole(37928-17-9)Related Product Information
- BenzenesulfonaMide, 3-[4-[4-(aMinosulfonyl)phenyl]-5-Methyl-3-isoxazolyl]-
- Valdecoxib IMpurity B
- Parecoxib
- 1-Hydroxy Valdecoxib
- Parecoxib Impurity 18
- Valdecoxib 3'-Sulfonyl Chloride IMpurity
- 5-Methyl-3-phenyl-4-(phenylMethyl)isoxazole
- 4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole
- N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetaMide
- 4-[(5-Methyl-3-phenyl-4-isoxazolyl)methyl]benzenesulfonamide
- 2-Phenylacetophenone
- 3-methyl -4,5-diphenyl-4,5-didydro-isoxazole
- Valdecoxib IMpurity-E
- Valdecoxib
- Deoxybenzoin Oxime
- 5-METHYL-3,4-DIPHENYL-4,5-DIHYDROISOXAZOL-5-OL
- Valdecoxib IMpurity D
- PARECOXIB SODIUM